Our products and services provide expert dosimetry analysis accompanied by the advice needed to address regulatory requirements, design appropriate imaging protocols, select patients mostly likely to respond, reduce toxicities to normal organs, and optimize patient outcomes.
Who We Are
We are focused on providing state-of-the art quantitative imaging and dosimetry services and products for developers and providers of radiopharmaceutical therapies.
Experts in the field
We draw our expertise from a combined 45+ years of NIH-funded research
Rapid's Unique expertise
Precision RPT is enabled by Rapid’s absorbed-dose calculations software
Service Number One
Absorbed-dose calculations accompanied by error bars improve confidence in dosimetry calculations
Service Number Two
Founders are innovators and academic thought-leaders in this field
Absorbed-dose calculations can accommodate alpha and beta emitter RPT
Service Number Three
Service Number Four
Uniting External Beam Radiation Therapy (XRT) and Radiopharmaceutical Therapy (RPT)
SPECT/CT or PET/CT images of RPT distribution used to estimate the spatial distribution of absorbed dose
Service Number Five
our experts
Our team is comprised of leading industry experts with extensive experience
George Sgouros
Co-founder
Eric Frey
Chief Scientific Officer
Michael Ghaly
Chief Technology Officer & Chief Operating Officer
Omid Moghadam
Chairman of The Board
Bin He
Chief of Medical
Physics Operations
Hany Mekhaeil
Operations Manager
Nadine Bonds
Director of Quality Assurance
Paul Seltzer
Director of Software Development
Andrew Laughland
Software Developer
David Niles
Medical Physicist
James Dormer
Medical Physicist
Kandice Bailey
Quality/Regulatory Specialist
PARTNERS
We understand the importance of collaboration in our industry and work closely with partners to help achieve our mission of developing innovative technology.
If you are interested in partnering with us, we want to hear from you.
AWARD WINNING TECHNOLOGY
Our next-generation dosimetry & radiopharmaceutical technology has been recognized by many prestigious organizations and we have received numerous awards and grants including:
SBIR Grant & Supplement
Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy
SBIR Contract
Software for Optimal Combination of External Beam Radiotherapy (XRT) and Radiopharmaceutical Therapy (RPT)
SBIR Grant
Quantitative SPECT of Difficult to Image Therapeutic Radionuclides: An Extensible Cloud-Based Framework
SBIR Contract
Treatment optimization by combined α-emitter (αRPT)/radiotherapy (XRT) dosimetry for prostate cancer patients.
SBIR Grant
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters
SBIR Contract
Targeted Radionuclide Therapy of Metastatic Liver Cancer: Patient Specific Optimization